Wednesday, April 22, 2026
29.4 C
Bengaluru

Interview with Salil Kallianpur

[wpfilebase tag=file id=95 tpl=download-button /]

Inside this Issue

1. Interview with Salil Kallianpur  with Anup Soans, Editor – MedicinMan

“There is much work to be done and a unified pharma industry can prove to be a valuable ally to the government.”

2. Patient-centricity: How Pharma Can Move from Intention to Action by Hanno Wolfram

Patient-centricity begins with moving from talking about the patient to talking to the patient 

3. The Corporate Halo Effect by Vivek Hattangadi

How a great corporate brand elevates a company’s products in the minds of doctors and patients

4. For a Positive Attitude, Clean Your Mind’s Windows  by Asheesh Kumar Patel

A bad attitude is a learned behavior and can be unlearned when we discover it’s source

5. The Three Transformations for Leadership  by Srinivasan Athmanathan

Three key professional traits that every successful leader must possess

6. Book Review: Feather in a C.A.P. by Kamalesh Subramanian 

A corporate saga with valuable lessons for professionals of all backgrounds

Hot this week

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation

The story of Healthium is not just one of...

Topics

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...
spot_img

Related Articles

spot_imgspot_img